|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 121 - 150 of 285 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Levonorgestrel Stada 1,5 mg tabletti SPC 2021-04-08
|
PL
|
Resepti
|
Levopidon 2,5 mg, 5 mg, 10 mg, 20 mg, 30 mg tabletti SPC 2024-03-21
|
PL
|
Resepti
|
Levopidon 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 55 mg, 60 mg, 65 mg, 70 mg, 75 mg oraaliliuos, kerta-annospakkaus SPC 2023-10-12
|
PL
|
Resepti
|
Levosimendan Altan 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2022-10-20
|
PL
|
Resepti
|
Levosimendan Amdipharm 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2023-05-24
|
PL
|
Resepti
|
Levosimendan Bioglan 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2023-06-07
|
PL
|
Resepti
|
Levosimendan Carinopharm 12.5 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos SPC 2022-08-04
|
PL
|
Resepti
|
Levosimendan EQL Pharma 2,5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2022-12-19
|
PL
|
Resepti
|
Levosimendan Fresenius Kabi 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2022-01-25
|
PL
|
Resepti
|
Levosimendan Kalceks 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2022-05-09
|
PL
|
Resepti
|
Levosimendan STADA 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2023-09-19
|
PL
|
Resepti
|
Levosimendan Tillomed 2.5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2022-09-16
|
PL
|
Resepti
|
Levothyroxine Orion 25, 50, 75, 100, 125 ja 150 mikrog tabletti SPC 2023-04-18
|
PL
|
Resepti
|
Levothyroxine SERB 200 mikrog/ml injektio-/infuusioneste, liuos SPC 2024-07-22
|
PL
|
Resepti
|
Lexaliz Adult 20 mg, 30 mg, 40 mg, 40 mg, 50 mg, 60 mg, 70 mg kapseli, kova SPC 2024-06-27
|
|
|
European Medicines Agency's website: Libmeldy - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Libmyris - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Librax 5 mg - 2.5 mg tabletti, päällystetty SPC 2023-10-13
|
|
|
European Medicines Agency's website: Libtayo - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Lidbree 42 mg-ml geeli kohtuun, SPC 2021-04-20
|
PL
|
Resepti
|
Lidocain c. adrenalin 5 mg-ml+10 mikrog-ml, 10 mg-ml+10 mikrog-ml, 20 mg-ml+5 mikrog-ml injektioneste, liuos SPC 2021-07-07
|
PL
|
Resepti
|
Lidocaine Baxter 10 mg-ml, 20 mg-ml injektioneste, liuos SPC 2021-12-01
|
PL
|
Resepti
|
Lidocaine Grindeks 10 mg-ml, 20 mg-ml injektioneste, liuos SPC 2024-07-31
|
PL
|
Resepti
|
Lidocard 20 mg-ml injektio-infuusioneste, liuos SPC 2022-12-12
|
PL
|
Resepti
|
Lidokain Aguettant 10 mg-ml, 20 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2024-06-03
|
PL
|
Itsehoito
|
Lidoposterin 50 mg-g rektaalivoide SPC 2023-03-06
|
PL
|
Resepti
|
Lilinorm 1 mg, 5 mg, 10 mg, 10mg_5mg kalvopäällysteinen tabletti SPC 2023-05-25
|
PL
|
Resepti
|
Linagliptin STADA 5 mg tabletti, kalvopäällysteinen SPC 2024-04-03
|
PL
|
Resepti
|
Linagliptin-Metformin Sandoz 2,5 mg-850 mg, 2,5 mg-1000 mg SPC 2024-09-12
|
PL
|
Resepti
|
Linatera 002mg-3mg tabletti SPC 2022-05-25
|
|
| |